Clinic
Wilmington Health PLLC
Wilmington Health PLLC was paid $6.85M by Medicaid between Jan 2018 and Dec 2024, across 104 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoWILMINGTON HEALTH PLLC
WILMINGTON, NC 28401
WILMINGTON, NC 28401
33aNPI1881632339assigned 06/04/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$6.85M
24GClaims556,805
24DCodes billed104
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in North Carolina
Rank by total paid#7 of 69
Median peer was paid$333K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,320 | $747K | |
| 2019 | 23,008 | $843K | |
| 2020 | 15,767 | $596K | |
| 2021 | 75,234 | $1.08M | |
| 2022 | 118,073 | $1.16M | |
| 2023 | 138,076 | $1.19M | |
| 2024incomplete | 168,327 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 60,791 | 52,738 | $3.24M |
| 99199 | Unlisted special service, procedure or report | 21% | 414,256 | 371,538 | $1.43M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.3% | 14,190 | 11,903 | $640K |
| 99242 | 2.9% | 2,954 | 2,701 | $196K | |
| 87428 | 2.6% | 3,459 | 2,653 | $180K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.7% | 1,168 | 418 | $117K |
| 99051 | 1.6% | 4,923 | 4,093 | $111K | |
| 99243 | 1.5% | 1,168 | 1,076 | $104K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.3% | 1,746 | 1,573 | $89K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.0% | 4,238 | 3,478 | $70K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,456 | 2,005 | $64K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 424 | 375 | $57K |
92 more codes
| 99223 | Prolong inpt eval add15 m | <1% | 737 | $52K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,228 | $51K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 870 | $47K |
| 17110 | <1% | 742 | $45K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 590 | $43K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,212 | $35K |
| 92567 | <1% | 1,712 | $20K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 401 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,359 | $18K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 115 | $17K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 93 | $16K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 480 | $13K |
| 0002A | <1% | 164 | $10K | |
| 93296 | <1% | 761 | $8K | |
| 93000 | <1% | 1,213 | $8K | |
| 0001A | <1% | 202 | $8K | |
| 92557 | <1% | 259 | $8K | |
| 0071A | <1% | 168 | $8K | |
| 11721 | <1% | 1,088 | $8K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 61 | $7K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 71 | $7K |
| 80076 | <1% | 681 | $6K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $6K |
| 92579 | <1% | 181 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,349 | $6K |
| 80061 | Lipid panel | <1% | 309 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 434 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 201 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 64 | $4K |
| 97803 | <1% | 124 | $4K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 33 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 66 | $4K |
| 73630 | <1% | 295 | $3K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 38 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 371 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 41 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 176 | $3K |
| 90686 | <1% | 1,846 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 227 | $3K |
| 86140 | <1% | 559 | $3K | |
| 0072A | <1% | 42 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 16 | $2K |
| 93295 | <1% | 94 | $2K | |
| 85652 | <1% | 568 | $2K | |
| 84439 | <1% | 161 | $2K | |
| 0003A | <1% | 39 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 183 | $1K |
| 20610 | <1% | 63 | $1K | |
| 93297 | <1% | 126 | $1K | |
| 71250 | <1% | 14 | $1K | |
| 93971 | <1% | 35 | $945.93 | |
| 94060 | <1% | 40 | $896.85 | |
| 95251 | <1% | 63 | $875.30 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 253 | $843.47 |
| 93922 | <1% | 30 | $708.30 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 236 | $701.33 |
| 97802 | <1% | 19 | $695.58 | |
| 99241 | <1% | 22 | $613.55 | |
| 94729 | <1% | 43 | $598.70 | |
| 94726 | <1% | 27 | $417.70 | |
| 93299 | <1% | 64 | $411.42 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 84 | $399.61 |
| 93970 | <1% | 16 | $370.88 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 44 | $357.00 |
| 95886 | <1% | 69 | $347.69 | |
| 95816 | <1% | 14 | $336.68 | |
| 11056 | <1% | 67 | $322.02 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 31 | $276.64 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 17 | $245.40 |
| 73610 | <1% | 19 | $236.20 | |
| 74018 | <1% | 15 | $233.05 | |
| 83655 | <1% | 15 | $179.16 | |
| 93298 | <1% | 25 | $169.94 | |
| 87807 | <1% | 14 | $155.43 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $143.64 |
| 93294 | <1% | 13 | $134.16 | |
| 92551 | <1% | 71 | $95.22 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 32 | $92.54 |
| 81025 | <1% | 14 | $90.09 | |
| 99173 | <1% | 149 | $81.43 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 19 | $79.69 |
| 99406 | <1% | 15 | $59.00 | |
| 93018 | <1% | 12 | $53.52 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 33 | $39.35 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 13 | $36.05 |
| 91300 | <1% | 489 | $11.55 | |
| 3074F | <1% | 12,093 | $7.44 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 32 | $3.32 |
| 3078F | 0% | 7,767 | $0.00 | |
| 3044F | 0% | 43 | $0.00 | |
| 91307 | 0% | 99 | $0.00 | |
| 3079F | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEARNS, PAMELA (CFO)